Parse Biosciences
Developer of a single-cell sequencing technology designed to perform experiments without the need for custom instrumentation. The company offers a platform that analyzes single-nucleus transcriptomes ...
Valuation
$225M
Market implied
Share Price
N/A
Total Raised
$100.3M
Last Round
N/A